- Thanks for posting this. It would be nice, of course, but I'm not sure their "heart" is in the right frame of mind.
I am rather horrified at the cost going toward this and it is clearly in the name of profit. I used to have this idea that researchers were concerned with really helping people, not about huge profits.
Not really medical reporting but business reporting. Focus on growing the business.
$70 Million just to buy into this? That's just beyond all reason. The implications / the future of medicine . . . ohhh.
" . . . AbbVie paid $70 million for an option to acquire the global rights to a drug being developed by Alvine Pharmaceuticals.
GlaxoSmithKline and Avalon Ventures, a venture capital firm, created a new company, Sitari Pharmaceuticals, which is pursuing celiac treatments. . . ." (end excerpt) -
Posted by Keebler (Member # 12673) on :
- What if even a portion of that $70. million were to be used to educated food manufacturers and helping them devise methods to keep gluten out of food products where it did not belong?
That so many food "products" contain non-necessary gluten in the first place is just absurd.
And WHO (just really, who? I would like to know but am too ill to research) is getting that $70. million? Who gets that kind of money for just handing out the privilege to someone to create a drug? Why should patients down the line have to make up for that? -
[ 04-29-2015, 05:38 PM: Message edited by: Keebler ]
Posted by Lymetoo (Member # 743) on :
That's insane.
Posted by Keebler (Member # 12673) on :
- And, oh, when it's reported patients are supposed to be just, oh so very happy. Uh?
They are using our illnesses to get rich. -
Posted by WPinVA (Member # 33581) on :
I guess this is positive, but personally I'd like better food labeling and awareness in restaurants instead.